Elicio Therapeutics

IN THE PRESS

Press Releases

Elicio Therapeutics Reports Inducement Grants - March 17, 2026

March 17, 2026

·

2 min read

Press Releases

Elicio Therapeutics Reports Full Year 2025 Financial Results and Provides Corporate Updates

March 13, 2026

·

13 min read

Press Releases

Elicio Therapeutics to Present at the TD Cowen 46th Annual Health Care Conference

February 25, 2026

·

2 min read

Press Releases

Elicio Therapeutics Reports Inducement Grants - February 18, 2026

February 18, 2026

·

2 min read

Press Releases

Elicio Therapeutics Reports Inducement Grants - January 16, 2026

January 19, 2026

·

2 min read

Press Releases

Elicio Therapeutics Reports Inducement Grants - December 16, 2025

December 17, 2025

·

2 min read

Press Releases

Elicio Therapeutics Reports Antigen Spreading to Patient-Specific Neoantigens Beyond mKRAS in Ongoing Phase 2 AMPLIFY-7P Trial

December 12, 2025

·

10 min read

Press Releases

Elicio Therapeutics Appoints Veteran CMC and Technical Operations Executive Marc J. Wolfgang as Chief Technology Officer

November 20, 2025

·

7 min read

Press Releases

Elicio Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Updates

November 14, 2025

·

12 min read

Press Releases

Elicio Therapeutics Reports Robust, Cytolytic mKRAS-Specific T Cell Responses Across Diverse Patient HLA in Ongoing Phase 2 AMPLIFY-7P Trial of ELI-002 7P and New ELI-004 Preclinical Data at SITC

November 10, 2025

·

13 min read

JOBS